OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

spacer

Recommended products of HLA-DQA1

divider

spacer

Your search returned 10 results.

Search:

TrueORF Gold TrueORF Gold = Expression Validated + Sequence Verified + Next-day shipment!

SKU Category Description $ Price Availability
TA311486 Antibody 100 ug Goat Anti-HLA-DQA2 & HLA-DQA1 Antibody 325 3-7 Days
SC118795 Human cDNA pCMV6-XL5 HLA (untagged)-Human major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1) 380 In Stock
RC209921 TrueORF Gold TrueORF Gold pCMV6-Entry HLA (Myc-DDK-tagged)-Human major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1) 380
98
In Stock
RC209921L1 Human ORF PS100064 Lenti ORF clone of Human major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1) , Myc-DDK-tagged 750 3-4 weeks
RC209921L2 Human ORF PS100071 Lenti ORF clone of Human major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1), mGFP tagged 830 3-4 weeks
RC509921 Human ORF pCMV6-Entry HLA (Myc-DDK-tagged)-Human major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1), (200ug) 500 1-2 weeks
RG209921 Human ORF pCMV6-AC-GFP HLA (GFP-tagged) - Human major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1) 420 In Stock
LY400774 Lysate Transient overexpression lysate of major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1) 280 5 days
TP309921 Protein Recombinant protein of human major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1) 680
398
In Stock
SC209262 3'-UTR Clone pMirTarget 3`UTR clone of major histocompatibility complex class II DQ alpha 1 (HLA-DQA1) for miRNA target validation 495 3-4 weeks

Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title